Navigation Links
Avanir Pharmaceuticals Reports Fiscal 2011 Fourth Quarter and Year End Financial Results
Date:12/12/2011

els of those medications and/or NUEDEXTA. NUEDEXTA is contraindicated in patients receiving drugs that both prolong QT interval and are metabolized by CYP2D6 (e.g., thioridazine and pimozide) and should not be used concomitantly with other drugs containing quinidine, quinine, or mefloquine. NUEDEXTA is contraindicated in patients taking monoamine oxidase inhibitors (MAOIs) or in patients who have taken MAOIs within the preceding 14 days. NUEDEXTA is contraindicated in patients with a known hypersensitivity to its components.

NUEDEXTA may cause serious side effects, including possible changes in heart rhythm. NUEDEXTA is contraindicated in patients with a prolonged QT interval, congenital long QT syndrome or a history suggestive of torsades de pointes, in patients with heart failure as well as patients with, or at risk of, complete atrioventricular (AV) block, unless the patient has an implanted pacemaker.

NUEDEXTA causes dose-dependent QTc prolongation. When initiating NUEDEXTA in patients at risk of QT prolongation and torsades de pointes, electrocardiographic (ECG) evaluation of QT interval should be conducted at baseline and 3-4 hours after the first dose.

The most common adverse reactions in patients taking NUEDEXTA are diarrhea, dizziness, cough, vomiting, weakness, swelling of feet and ankles, urinary tract infection, flu, elevated liver enzymes, and flatulence.

NUEDEXTA may cause dizziness. Precautions to reduce the risk of falls should be taken, particularly for patients with motor impairment affecting gait or a history of falls.

Patients should take NUEDEXTA exactly as prescribed. Patients should not take more than 2 capsules in a 24-hour period, make sure that there is an approximate 12-hour interval between doses, and not take a double dose after they miss a dose.

These are not all the risks from use of NUEDEXTA. For additional important safety information about NUEDEXTA, please see the full Prescribing Informat
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Avanir Pharmaceuticals Announces Date of Fiscal 2011 Fourth Quarter and Year End Financial Results and Conference Call
2. Avanir Pharmaceuticals to Participate in Piper Jaffray Health Care Conference
3. Avanir Pharmaceuticals Announces EMA Acceptance of Marketing Authorization Application for NUEDEXTA
4. Avanir Pharmaceuticals Submits European Marketing Authorization Application for NUEDEXTA
5. Avanir Pharmaceuticals to Present Data at the 2011 American Congress of Rehabilitation Medicine/American Society for Neurorehabilitation Medicine Annual Conference
6. Avanir Pharmaceuticals to Participate in Two Investor Conferences
7. Avanir Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference
8. Avanir Pharmaceuticals Files Lawsuits Against Par and Actavis for Infringement of NUEDEXTA Patents
9. Avanir Pharmaceuticals Reports Fiscal 2011 Third Quarter Financial Results
10. Avanir Pharmaceuticals Announces Appointment of Dr. Joao Siffert as Senior Vice President Research and Development
11. Avanir Pharmaceuticals to Present at Two Investor Conferences in August
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 2014 /PRNewswire-iReach/ -- Full Service CRO WCCT ... Vice President of Business Development. Peter has been in ... number of different business development positions with some of ... primarily related to business development/sales management and marketing.  The ... makes him a key and strategic asset to WCCT ...
(Date:7/25/2014)... Tobago , July 25, 2014  The ... & Tobago Ministry of Health approved the introduction ... significantly increases the cure rate from Hepatitis C, ... the genotype 1 virus. Telaprevir is available in ... brand INCIVO®. Photo - http://www2.prnewswire.com.br/imgs/pub/2014-07-25/original/2026.jpg ...
(Date:7/25/2014)... , July 25, 2014  Solanbridge Group Inc ... acquired the majority interest in Buzznbrewz.com and the Letter ... replaced with a fully executed Purchase Agreement. ... stated "We are proud to have Mr. David ... decades of experience in the private sector and developed ...
Breaking Medicine Technology:Contract Research Organization WCCT Global Welcomes Peter Nieto as Vice President of Business Development 2The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3Solanbridge Group Inc Announces Acquisition of Buzznbrewz.com 2
... Pharmaceuticals, a leading manufacturer of critical care products, celebrates ... new website. In the last four years, Novis has ... technology (RXID), customer focus, service excellence and superior compliance ... provide our customers with outstanding service. We have a ...
... TITUSVILLE, N.J., April 14, 2011 Ortho-McNeil Neurologics ... is voluntarily recalling two lots of TOPAMAX ® ... shipped between 10/19/2010 and 12/28/2010 and distributed in ... encompasses approximately 57,000 bottles of TOPAMAX ® , ...
Cached Medicine Technology:Novis Pharmaceuticals Celebrates Four Years With New Website Launch 2Ortho-McNeil Neurologics Voluntarily Recalls Two Lots of TOPAMAX® 2Ortho-McNeil Neurologics Voluntarily Recalls Two Lots of TOPAMAX® 3Ortho-McNeil Neurologics Voluntarily Recalls Two Lots of TOPAMAX® 4Ortho-McNeil Neurologics Voluntarily Recalls Two Lots of TOPAMAX® 5
(Date:7/26/2014)... The European Artificial lift market report defines and segments ... of revenue. The artificial lift market in Europe is estimated ... $5.4 billion by 2018, at a CAGR of 8.8% from ... European artificial lift market report, to get an idea of ... segmentation in European Artificial lift market, and is supported by ...
(Date:7/26/2014)... European gas chromatography reagents report defines and segments the concerned ... gas chromatography reagents market in Europe is valued at $ ... around $445.5 million by 2018, at a CAGR of 8.6 ... of the European gas chromatography reagents market, to get an ... a glimpse of the segmentation of gas chromatography reagents market ...
(Date:7/26/2014)... 2014 Recently, iFitDress.com, a popular supplier ... has unveiled its new range of high quality party ... the brand new items; they are now provided at ... iFitDress.com is one of the leading suppliers in the ... the wholesale party dresses have flattering looks ...
(Date:7/26/2014)... July 26, 2014 The number of ... and federal litigations since the 2012 recall of Rejuvenate ... filings, Bernstein Liebhard LLP reports. According to a case ... cases have been filed in the New Jersey’s Bergen ... and the ABG II Modular Hip Stem Litigation, No. ...
(Date:7/26/2014)... Pools can provide much-needed relief from the summer heat, ... too much chlorinated water, experts warn. Amid the ... get water in their mouth. Some kids may even ... their parents. Although swallowing a small amount of ... realize that ingesting too much can lead to chlorine ...
Breaking Medicine News(10 mins):Health News:Europe Artificial Lift Services Market is Expected to Reach $5.4 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Artificial Lift Services Market is Expected to Reach $5.4 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Artificial Lift Services Market is Expected to Reach $5.4 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Artificial Lift Services Market is Expected to Reach $5.4 Billion in 2018 - New Report by MicroMarket Monitor 5Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 5Health News:High Quality Wholesale Party Dresses Online at iFitDress.com 2Health News:Stryker Hip Lawsuit Filings in State and Federal Litigations Continue to Rise, Bernstein Liebhard LLP Reports 2Health News:Stryker Hip Lawsuit Filings in State and Federal Litigations Continue to Rise, Bernstein Liebhard LLP Reports 3Health News:Don't Let Kids Drink Pool Water 2
... ... for their innovative solutions for reducing stress and improving health and well-being, is offering ... can be given as gifts. Their Beautiful Heart Award is expected to be very ... corner. , ...
... Feb. 4   When Mary Gill went to bed ... even Mary. She was thin and 42 years old. She exercised regularly, ... recipe for turning a young mom into a tragic statistic. , "Heart ... that night with an upset stomach, I wasn,t thinking heart attack." , ...
... , LACHEN, ... Octapharma USA will accept applications until ... , which supports clinical or pre-clinical research focused on human protein therapies ... reviewed in April. , Octapharma AG , one of the largest ...
... discovered unexpected properties for a precursor to melatonin, the ... from the neurotransmitter serotonin in a daily rhythm that ... previously thought to have effects separate from those of ... shown that N-acetylserotonin can stimulate the same circuits in ...
... National Heart, Lung, and Blood Institute (NHLBI), part of ... totaling $23.6 million to begin preclinical testing of devices ... those who develop heart failure. The four-year program is ... Each year in the United States, nearly 1,800 infants ...
... ... its Cryopak subsidiary in Maromme, France. Officially starting operations in March of 2009, Cryopak, ... scale to companies across Europe. , ... Edison, NJ (PRWEB) February 4, 2010 -- www.cryopak-europe.com-- TCP Reliable has ...
Cached Medicine News:Health News:HeartMath Offers Free Certificates that Celebrate Love and the Heart 2Health News:HeartMath Offers Free Certificates that Celebrate Love and the Heart 3Health News:Texas Health Dallas Launches Screening Program for Female Heart Disease 2Health News:Texas Health Dallas Launches Screening Program for Female Heart Disease 3Health News:Octapharma Accepting Applications for Research Grants Through March 31 2Health News:Octapharma Accepting Applications for Research Grants Through March 31 3Health News:Octapharma Accepting Applications for Research Grants Through March 31 4Health News:Melatonin precursor stimulates growth factor circuits in brain 2Health News:NHLBI funds preclinical tests on devices for infants and children with congenital heart defects 2Health News:NHLBI funds preclinical tests on devices for infants and children with congenital heart defects 3Health News:Cryopak France Opening Signifies New Vision for Global Manufacturing for the Cold Chain Industry 2
1-Day Acuvue brand contact lenses offer the healthiest, most convenient way to wear contact lenses. There's no lens care or messy solutions required, just wear them one day and throw them away....
PLX40s, 40 Watt Sealed CO2 Laser System....
... The UltraPulse system's capability to quickly deliver ... one pulse allows for powerful single-pulse ablation. ... UltraPulse system the coldest and cleanest CO2 ... power is combined with the independent adjustment ...
... The NIDEK OPD-Scan II provides information ... and pupillometry in one unit, utilizing ... specifically to measure normal to highly ... variety of data maps to provide ...
Medicine Products: